Fewer than one out of five anticancer drugs that entered pediatric clinical testing advanced to phase 3 trials, and fewer still earned pediatric regulatory approval, according to recent analysis.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/few-pediatric-cancer-drugs-reach-phase-3-or-approval-2026a1000fsh?src=rss
Author :
Publish date : 2026-05-15 12:43:00
Copyright for syndicated content belongs to the linked Source.
